Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Lancet (London, England)|April 1, 2026
Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trialRonak Delewi, Hugo M Aarts, Gijs M Broeze, et al.
JAMA Network Open|October 16, 2024
Upper- vs Lower-Extremity Secondary Access During Transcatheter Aortic Valve Implantation: A Randomized Clinical TrialGeert A A Versteeg, Maxim J P Rooijakkers, Kimberley I Hemelrijk, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 23, 2024
Upper extremity versus lower extremity for secondary access during transcatheter aortic valve implantation: rationale and design of the randomised TAVI XS trialMaxim J P Rooijakkers, Geert A A Versteeg, Kimberley I Hemelrijk, et al.
American Heart Journal|November 2, 2025
Routine versus selective protamine administration to reduce bleeding after TAVI: Rationale and design of the POPular ACE TAVI trialDaniël C Overduin, Dirk Jan van Ginkel, Christophe Dubois, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 13, 2026
Extremity Function After Transfemoral Transcatheter Aortic Valve Implantation: A TAVI XS Sub-StudyGeert A A Versteeg, Maxim J P Rooijakkers, Kimberley I Hemelrijk, et al.
American Heart Journal|December 14, 2024
Deferral of routine percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: Rationale and design of the PRO-TAVI trialHugo M Aarts, Kimberley I Hemelrijk, Gijs M Broeze, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 22, 2023
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trialDirk Jan van Ginkel, Willem L Bor, Christophe L F Dubois, et al.
The New England Journal of Medicine|August 31, 2024
Continuation versus Interruption of Oral Anticoagulation during TAVIDirk Jan van Ginkel, Willem L Bor, Hugo M Aarts, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulationDaniël C Overduin, Dirk Jan van Ginkel, Willem L Bor, et al.
Pageof 2